Answers are grounded in this paper and cite their sources.
The relationship between age and homologous recombination repair (HRR) and DNA damage response (DDR) pathway alterations in prostate cancer (PCa) remains incompletely understood. This study evaluated age-stratified HRR/DDR alteration patterns and recurrent genomic co-alterations using tumor-based targeted next-generation sequencing (NGS). In this single-center retrospective study, 101 patients with PCa were stratified into <65 (n = 25) and ≥65 (n = 76) age groups and analyzed using a 93-gene tumor-based NGS panel. Only alterations classified as pathogenic or likely pathogenic (P/LP) in the original clinical molecular reports issued between 2019 and 2025 were included in the analyses of Core HRR, expanded DDR, individual genes, genomic alteration burden, and gene co-alterations. Logistic regression models adjusted for Grade Group and Benjamini–Hochberg false discovery rate (FDR) correction were applied. Within the predefined 93-gene analytical set, 83 of 101 patients (82.2%) had at least one historically recorded pathogenic or likely pathogenic (P/LP) alteration. Core HRR alterations were more frequent in the <65-year group than in the ≥65-year group (36.0% vs. 15.8%; p = 0.0455). A comparable effect estimate was observed after adjustment for Grade Group (aOR = 2.94; 95% CI: 1.04–8.34; p = 0.0425), although the association did not meet the conventional significance threshold after FDR correction (q = 0.0627). When age was analyzed as a continuous variable, no statistically significant association with Core HRR alterations was observed (OR per 5-year increase = 0.83; 95% CI: 0.64–1.08; p = 0.162). Expanded DDR alterations (p = 0.251), total genomic alteration burden, and individual gene frequencies showed no significant differences between age groups. Post hoc sensitivity analyses excluding low-VAF Core HRR records or additionally excluding records with unavailable VAF/depth information yielded nonsignificant age-group comparisons (p = 0.0656 and p = 0.1044, respectively), indicating uncertainty regarding the robustness of the observed association. Exploratory co-detection analysis identified statistically significant but nested associations involving BLM, ATR, RAD50, and HERC1. These patterns were also observed in a fixed-margin sensitivity analysis; however, they do not establish functional cooperation or age-specific co-alteration architecture. Core HRR alterations were more frequently reported in patients aged <65 years; however, this association did not remain statistically significant after FDR correction and was not supported by a significant continuous-age association. Given the historical clinical P/LP classifications, limited clinical annotation, and incomplete retrospective technical validation, these findings should be considered exploratory and require confirmation in independently characterized cohorts.
No takes yet. Share an insight, caveat, or question.
Erdoğdu et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: